MUST READ!
Agora Financial hosted a pitch by Louis Basenese to sell his service to new subscribers. I read the transcript of the pitch. Without naming the stock he describes a company that sounds exactly like CTSO.
Louis: Yes, the tiny company that I said has a shot to deliver gains of 1,233% or higher…
The thing with this opportunity … it has a chance to return the biggest chartbreaking gains I’ve seen to date…
Robert: What about this company has you so excited?
Louis: For starters, it’s one of the TINIEST companies I’ve ever recommended.
The total worth of this small biotech is roughly $150 million.
And get this …
They’re perfectly positioned to claim a lion’s share of a $20 billion market.
That means they’re the perfect takeover target for huge gains.
Robert: Correct me if I’m wrong but you’re saying the opportunity they have is worth 133 times the value of the entire company?
Louis: Yes, and here’s the bottom line…
If the takeover announcement comes at just 10% of the market… meaning this $150 million company gets bought out for just $2 billion…
And that’s conservatively speaking…
We’re looking at a gain of 1,233%.
That turns this $4.80 stock… into a $59.18 stock… virtually overnight.
Now I’ve got to ask, what’s the secret that’s making this company tick?
Louis: Without getting into a full biology lesson here, this biotech company can help prevent life threatening conditions like liver failure… sepsis… the flu… just to name a few…
Basically, this company has developed a best of breed technology that “cleans your blood.”
It removes all the deadly “side effects” that live in our blood stream…
And then with the help of a special machine… pumps the clean blood back into your body.
In fact, their technology has already proven capable of “purifying” all the blood in your entire body… more than 70 times… in just one day’s worth of treatment.
See -- that $20 billion opportunity I just told you about…
That’s just ONE market opportunity for this tiny sub $150 million firm…
See, their technology has also proven effective for open heart surgery… part of a $57 billion market…
Not to mention dozens of potential future applications like:
Cancer Immunotherapy… which generates upwards of $100 billion in drug sales EACH year…
Cancer Cachexia… a muscle destroying condition that affects nearly HALF of all cancer patients…
Multiple Sclerosis… a potential $24.8 billion market…
Lupus… a potential $3.2 billion market…
Inflammatory Bowel Disease… a potential $1.5 billion market…
Robert: So let me get this right… We’re talking about a $150 million company potentially having $199.5 BILLION worth of opportunity.
Louis: Yep. And that’s not even counting all the other products the company has in the pipeline.
Now I don’t have time to get into all that here…
But the company’s work is so highly respected, it’s currently receiving millions of dollars to fast-track it’s products from The Joint Program for Chemical and Biological Defense… DARPA… even the U.S. Army…
I can imagine it’s only a matter of time before this company gets bought out.
Louis: Exactly. And when it does… BOOM!
Massive chartbreaking gains.
In fact, according to my research, the company is already fielding interest from dozens of players…
Which is why the time to get in for the biggest gains is NOW.
And here’s the thing…
Because this company is so tiny, it’s critical for folks to act immediately so they DON’T go chasing the stock once it shoots up over my recommended strict buy up to price.
